The new chief at the Food and Drug Administration's tobacco center has inherited a raft of problems.
and flavored cigars, which disproportionately impact Black smokers and young people.
Q: The FDA is working on a number of proposals that would fundamentally change the U.S. tobacco landscape, including banning menthol cigarettes and flavored cigars. When will those be ready and how will they impact public health? At the same time, we have a rapidly diversifying product landscape. Particularly among youth, I continue to be very concerned about the use of emerging products, including e-cigarettes. And when it comes to youth there’s no redeeming aspects of tobacco product use.
A: I’m fully aware of the misperceptions that are out there and aren’t consistent with the known science. We do know that e-cigarettes — as a general class — have markedly less risk than a combustible cigarette product. That said, I think it’s very critical that we inform any communication campaigns using science and evidence. It has to be very carefully thought out to ensure that we’re maximizing impact and avoiding unintended consequences.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Lire la suite »
Pfizer seeks to expand omicron booster to 5- to 11-year-oldsIf the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
Lire la suite »
Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11. pfizer booster kprc2 click2houston vaccine
Lire la suite »
Pfizer seeks to expand omicron booster to 5- to 11-year-oldsIf the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
Lire la suite »
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11109.6 million people living in the U.S. have had a COVID booster, equal to 48.7% of the vaccinated population, the CDC’s tracker shows. Some 4.4 million people have had the new bivalent vaccines that target the latest omicron subvariants.
Lire la suite »